Literature DB >> 16263596

Placental tissue levels of nonesterified polyunsaturated fatty acids in normal and preeclamptic pregnancies.

Yuping Wang1, Scott W Walsh, Helen H Kay.   

Abstract

OBJECTIVE: We previously reported that maternal plasma levels of nonesterified polyunsaturated fatty acids were decreased in women with preeclampsia as compared to women with normal pregnancies. Polyunsaturated fatty acids of the n-6 and n-3 families are essential dietary fatty acids. The n-6 polyunsaturated fatty acids are involved in inflammatory reactions, whereas n-3 polyunsaturated fatty acids protect against inflammation.
METHODS: In this study, we investigated the composition of nonesterified polyunsaturated fatty acids in placental tissue of normal and preeclamptic pregnancies. Linoleic (18:2) and arachidonic (20:4, AA) acids of the n-6 family and linolenic (18:3), eicosapentaenoic (20:5, EPA) and docosahexaenoic (22:6, DHA) acids of the n-3 family were analyzed.
CONCLUSIONS: We found that total concentrations of nonesterified polyunsaturated fatty acids were lower in placental tissues from preeclamptic pregnancies than from normal pregnancies. Both n-6 and n-3 polyunsaturated fatty acids were decreased. The decrease in n-6 polyunsaturated fatty acids was due to a decrease in AA. The concentration of linoleic acid was not altered. For n-3 polyunsaturated fatty acids, DHA was decreased, with no change in linolenic acid. The percentage decrease in EPA and DHA was greater than for AA, so the ratio of n-6 to n-3 polyunsaturated fatty acids was two-fold higher in preeclampsia than normal pregnancy. Because the levels of essential fatty acids, linoleic (18:2) and linolenic (18:3), are preserved but levels of metabolites (AA and DHA) are reduced, we speculate that placental oxidative stress and increased conversion of AA to thromboxane are responsible for the decreased concentrations of polyunsaturated fatty acids in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263596     DOI: 10.1080/10641950500281118

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  8 in total

Review 1.  Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status.

Authors:  Lotte Lauritzen; Susan E Carlson
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

2.  Reduced Maternal Erythrocyte Long Chain Polyunsaturated Fatty Acids Exist in Early Pregnancy in Preeclampsia.

Authors:  Nisha S Wadhwani; Ankita S Narang; Savita S Mehendale; Girija N Wagh; Sanjay A Gupte; Sadhana R Joshi
Journal:  Lipids       Date:  2015-12-01       Impact factor: 1.880

3.  Comprehensive fatty acid fractionation profilling in preeclampsia: a case control study with multivariable analysis.

Authors:  Herlambang Herlambang; Anggelia Puspasari; Citra Maharani; Rina Nofri Enis; Susan Tarawifa; Amelia Dwi Fitri; Huntari Harahap; Asro Hayani Harahap; Erny Kusdiyah; Mas Rizky Anggun Adipurna Syamsunarno
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-03       Impact factor: 3.007

4.  Omega-3 Fatty Acid supplementation during pregnancy.

Authors:  James A Greenberg; Stacey J Bell; Wendy Van Ausdal
Journal:  Rev Obstet Gynecol       Date:  2008

5.  The association between dietary fatty acid intake and the risk of developing preeclampsia: a matched case-control study.

Authors:  Shu-Na Li; Yan-Hua Liu; Ze-Yan Luo; Yun-Feng Cui; Yuan Cao; Wen-Jun Fu; Wei-Feng Dou; Dan-Dan Duan; Xian-Lan Zhao; Yu-Ming Chen; Quan-Jun Lyu; Qing-Shan Chen; Fang-Fang Zeng
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 6.  Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.

Authors:  Jorge A Carvajal
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

7.  Differential regional fatty acid distribution in normotensive and preeclampsia placenta.

Authors:  Alka Rani; Preeti Chavan-Gautam; Savita Mehendale; Girija Wagh; Sadhana Joshi
Journal:  BBA Clin       Date:  2015-06-20

Review 8.  Neuroinflammatory Triangle Presenting Novel Pharmacological Targets for Ischemic Brain Injury.

Authors:  Zaib A Shaheryar; Mahtab A Khan; Ch Sherjeel Adnan; Awais Ali Zaidi; Daniel Hänggi; Sajjad Muhammad
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.